Adverse drug reactions to dopamine agoni
✍
Santiago Perez-Lloret; Emmanuelle Bondon-Guitton; Olivier Rascol; Jean-Louis Mon
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 71 KB
## Abstract Pharmacodynamical differences between dopamine agonists (DAs) suggest differences in their adverse drug reactions (ADRs) profile. In this study, frequencies of ADR to DAs or levodopa reports in the French Pharmacovigilance Database were explored. Reports occurring between January 1, 198